Why the study?
Although TAVI is less invasive than surgical aortic valve replacement, some patients require prolonged hospitalization.
Does pre-procedural use of ACE inhibitors/ARB or statins reduce prolonged hospitalization in elderly patients undergoing trans-femoral TAVI?
Does pre-procedural use of ACE inhibitors/ARB or statins reduce prolonged hospitalization in elderly patients undergoing trans-femoral TAVI?
Pre-procedural use of ACE inhibitors/ARBs or statins may be inversely associated with prolonged hospitalization following trans-femoral TAVI.
INTRODUCTION: Transcatheter aortic valve implantation (TAVI) has grown to be an alternative treatment for severe symptomatic aortic valve stenosis (AS) in elderly patients. Although TAVI is a less invasive surgery than surgical aortic valve replacement, some patients may require prolonged hospitalization. AIM: To find the determinants of prolonged hospitalization in patients who underwent trans-femoral TAVI. MATERIAL AND METHODS: = 20). We compared clinical characteristics between the two groups, and multivariate logistic regression analysis was performed to find the determinants of prolonged hospitalization. RESULTS: < 0.01) were significantly associated with prolonged hospitalization. CONCLUSIONS: incremental), taking ACE inhibitors/ARB or statins before the procedure were inversely associated with prolonged hospitalization in patients who underwent trans-femoral TAVI.
No takes yet. Share an insight, caveat, or question.
Taniguchi et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: